Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva. Despite promising data and market potential, UroGen's low market cap ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Cloudy. Slight chance of a shower. Winds east to northeasterly 15 to 20 km/h tending east to southeasterly 15 to 25 km/h in the evening. Sun protection recommended from 9:00 am to 5:20 pm, UV Index ...